About this trial
The aim of this study was to obtain short- and long-term performance and safety data of cross-linked hyaluronic acid-based adhesion barrier gel used to prevent intrauterine adhesion formation.
Eligibility criteria
Qualifiers
Female patients aged 18 and over
Patients who were treated with operative hysteroscopy for intrauterine pathology (endometrial polips, myomas with uterine cavity deformation, uterine septa, intrauterine adhesion, ovarian cyst, endometrial cyst, etc.)
Patients who had undergone operative hysteroscopy at least 30 days and at most 6 months ago
Patients who had second-look office hysteroscopy at least once after an operative hysteroscopy
Disqualifiers
Children and adolescents under 18 years of age
Having a body weight of more than 100 kg
Surgeries complicated by excessive bleeding; estimated blood loss of more than 100 cc
Surgeries complicated with uterine perforation
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Semikal Technology
Lead sponsor
Antalya Training and Research Hospital
Collaborator